Literature DB >> 2722672

UCN-01 and UCN-02, new selective inhibitors of protein kinase C. I. Screening, producing organism and fermentation.

I Takahashi1, K Asano, I Kawamoto, T Tamaoki, H Nakano.   

Abstract

In the course of continued screening program for new selective inhibitors of protein kinase C (PKC), fermentation broths from over 5,000 soil isolates were screened for their inhibitory activity of PKC. HPLC analysis of active cultures revealed that five different strains (N-71, N-115, N-126, N-128 and N-139) of Streptomyces isolated from various local soil samples were found to produce staurosporine and related compounds. Of these strains, N-126, a high producing strain, was found to produce new selective inhibitors of PKC, UCN-01 and its stereoisomer, UCN-02. The pH control of fermentation resulted in an increase of the production of UCN-01 and UCN-02.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722672     DOI: 10.7164/antibiotics.42.564

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

1.  Identification of indolepyruvic acid as an intermediate of rebeccamycin biosynthesis.

Authors:  K S Lam; S Forenza; T W Doyle; C J Pearce
Journal:  J Ind Microbiol       Date:  1990-12

2.  Curcumin protects against staurosporine toxicity in rat neurons.

Authors:  Xiao-Yan Qin; Ji-Hui Lv; Jia Cui; Xue Fang; Yan Zhang
Journal:  Neurosci Bull       Date:  2012-10-03       Impact factor: 5.203

Review 3.  Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.

Authors:  Sameh Mikhail; Christopher Albanese; Michael J Pishvaian
Journal:  Am J Pathol       Date:  2015-03-05       Impact factor: 4.307

4.  Cytotoxic Indolocarbazoles from Actinomadura melliaura ATCC 39691.

Authors:  Khaled A Shaaban; Sherif I Elshahawi; Xiachang Wang; Jamie Horn; Madan K Kharel; Markos Leggas; Jon S Thorson
Journal:  J Nat Prod       Date:  2015-06-19       Impact factor: 4.050

5.  Disposition in mice of 7-hydroxystaurosporine, a protein kinase inhibitor with antitumor activity.

Authors:  D L Hill; K F Tillery; L M Rose; C F Posey
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Structure elucidation and anticancer activity of 7-oxostaurosporine derivatives from the Brazilian endemic tunicate Eudistoma vannamei.

Authors:  Paula Christine Jimenez; Diego Veras Wilke; Elthon Gois Ferreira; Renata Takeara; Manoel Odorico De Moraes; Edilberto Rocha Silveira; Tito Monteiro Da Cruz Lotufo; Norberto Peporine Lopes; Leticia Veras Costa-Lotufo
Journal:  Mar Drugs       Date:  2012-05-21       Impact factor: 6.085

7.  A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells.

Authors:  Binita Das; Beth K Neilsen; Kurt W Fisher; Drew Gehring; Youcai Hu; Deanna J Volle; Hyun Seok Kim; Jamie L McCall; David L Kelly; John B MacMillan; Michael A White; Robert E Lewis
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

Review 8.  Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.

Authors:  Satheesh Kumar Palanisamy; N M Rajendran; Angela Marino
Journal:  Nat Prod Bioprospect       Date:  2017-01-17

9.  UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery.

Authors:  S Abe; T Kubota; Y Otani; T Furukawa; M Watanabe; K Kumai; T Akiyama; S Akinaga; M Kitajima
Journal:  Jpn J Cancer Res       Date:  2001-05

10.  A New Analogue of Echinomycin and a New Cyclic Dipeptide from a Marine-Derived Streptomyces sp. LS298.

Authors:  Xin Zhen; Ting Gong; Fu Liu; Pei-Cheng Zhang; Wan-Qi Zhou; Yan Li; Ping Zhu
Journal:  Mar Drugs       Date:  2015-11-18       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.